Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-site, Multi-country Evaluation of Innovative Ovarian Cancer Biomarker Assays. (DISARM Clinical Study B-CSB)

NCT07693894 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.

NCT NCT07693894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07693894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-site, Multi-country Evaluation of Innovative Ovarian Cancer Biomarker Assays. (DISARM Clinical Study B-CSB)
Lead sponsor
National and Kapodistrian University of Athens
Phase
Observational
Overall status
Recruiting
Start date
August 3, 2026
Completion date
December 31, 2028
Enrollment
2,080 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer